☆ 4.7 Letter

SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load

JOURNAL OF INFECTION (2021)

Journal

JOURNAL OF INFECTION

Volume 82, Issue 3, Pages E38-E41

Publisher

W B SAUNDERS CO LTD

DOI: 10.1016/j.jinf.2020.11.024

Keywords

-

Categories

Infectious Diseases

Funding

Plan Nacional de I + D + i
Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI) [RD16/0016/0001, RD16/0016/0005, RD16/0016/0007, RD16/0016/0009, RD16/0016/0010, R D16/0016/0013]
European Development Regional Fund A way to achieve Europe, Operative program Intelligent Growth
Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion [COV20/00580, COV20/00370]
Servicio Andaluz de Salud, Junta de Andalucia, Spain [C-0059-2018]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Virology

SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19

Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Yoshihiro Yoshida, Yusuke Takegoshi, Makito Kaneda, Yushi Murai, Kou Kimoto, Akitoshi Ueno, Yuki Miyajima, Yasutaka Fukui, Miyuki Kimura, Hiroshi Yamada, Ippei Sakamaki, Yoshihiro Yamamoto

Summary: This study found a relatively high proportion of SARS-CoV-2 RNAemia in COVID-19 patients and its association with clinical severity, suggesting the potential utility of combining serum testing with NP tests as a prognostic indicator for COVID-19. Among patients with RNAemia, the viral loads of NP swabs were correlated with disease severity and mortality, with higher quality than each separate test.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Plasma Is Associated With Intensive Care Unit Admission and Mortality in Patients Hospitalized With Coronavirus Disease 2019

Christian Prebensen, Peder L. Myhre, Christine Jonassen, Anbjorg Rangberg, Anita Blomfeldt, My Svensson, Torbjorn Omland, Jan-Erik Berdal

Summary: Detection of severe acute respiratory syndrome coronavirus 2 RNA in the circulation may be associated with disease severity and poor outcomes in patients hospitalized with coronavirus disease 2019.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral Culture

Andrew Pekosz, Valentin Parvu, Maggie Li, Jeffrey C. Andrews, Yukari C. Manabe, Salma Kodsi, Devin S. Gary, Celine Roger-Dalbert, Jeffry Leitch, Charles K. Cooper

Summary: SARS-CoV-2 antigen testing may be positive early in the disease course, aiding in determining infectious risk, with a slightly better detection of infectious virus compared to rt-PCR.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral Culture

Andrew Pekosz, Valentin Parvu, Maggie Li, Jeffrey C. Andrews, Yukari C. Manabe, Salma Kodsi, Devin S. Gary, Celine Roger-Dalbert, Jeffry Leitch, Charles K. Cooper

Summary: Recent studies indicate that SARS-CoV-2 antigen testing demonstrates a higher positive predictive value in the early stages of infection and shows good consistency with culture results. This testing method can significantly aid in determining the risk of carrying infectious virus.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes

Jana L. Jacobs, William Bain, Asma Naqvi, Brittany Staines, Priscila M. S. Castanha, Haopu Yang, Valerie F. Boltz, Simon Barratt-Boyes, Ernesto T. A. Marques, Stephanie L. Mitchell, Barbara Methe, Tolani F. Olonisakin, Ghady Haidar, Thomas W. Burke, Elizabeth Petzold, Thomas Denny, Chris W. Woods, Bryan J. McVerry, Janet S. Lee, Simon C. Watkins, Claudette M. St Croix, Alison Morris, Mary F. Kearney, Mark S. Ladinsky, Pamela J. Bjorkman, Georgios D. Kitsios, John W. Mellors

Summary: This study found that SARS-CoV-2 vRNA was detected in the plasma of COVID-19 patients, with the highest rates in ICU patients. Higher levels of vRNA were associated with more severe disease, patient outcomes, and specific inflammatory biomarkers.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Influence of Nasopharyngeal Viral Load on the Spread of the Omicron BA.2 Variant

Marion Migueres, Chloe Dimeglio, Jean Michel Mansuy, Florence Abravanel, Stephanie Raymond, Justine Latour, Nicolas Jeanne, Noemie Ranger, Sebastien Lhomme, Karine Saune, Pauline Tremeaux, Jacques Izopet

Summary: Using variant typing polymerase chain reaction, this study describes the evolution of SARS-CoV-2 Omicron sublineages between December 2021 and mid-March 2022. The advantage of the BA.2 variant over BA.1 is not attributed to greater nasopharyngeal viral loads.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Immunology

High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease

Catherine A. Hogan, Bryan A. Stevens, Malaya K. Sahoo, ChunHong Huang, Natasha Garamani, Saurabh Gombar, Fumiko Yamamoto, Kanagavel Murugesan, Jason Kurzer, James Zehnder, Benjamin A. Pinsky

Summary: This study examined the presence of SARS-CoV-2 RNA in plasma of COVID-19 patients and found an association between RNAemia and clinical severity. A high proportion of RNAemia was detected, with all deaths occurring in patients with detectable RNAemia.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Correlation of SARS-CoV-2 Nasopharyngeal CT Values With Viremia and Mortality in Adults Hospitalized With COVID-19

Karl Hagman, Magnus Hedenstierna, Jacob Widaeus, Emelie Arvidsson, Berit Hammas, Lena Grillner, Jan Jakobsson, Patrik Gille-Johnson, Johan Ursing

Summary: There is a correlation between nasopharyngeal CT values and viremia in patients hospitalized for COVID-19, with higher mortality risk observed in patients with low CT values compared to those with high CT values.

OPEN FORUM INFECTIOUS DISEASES (2022)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome

Sonsoles Salto-Alejandre, Judith Berastegui-Cabrera, Pedro Camacho-Martinez, Carmen Infante-Dominguez, Marta Carretero-Ledesma, Juan Carlos Crespo-Rivas, Eduardo Marquez, Jose Manuel Lomas, Claudio Bueno, Rosario Amaya, Jose Antonio Lepe, Jose Miguel Cisneros, Jeronimo Pachon, Elisa Cordero, Javier Sanchez-Cespedes

Summary: The study assessed the ability of nasopharyngeal SARS-CoV-2 viral load at first patient's hospital evaluation to predict unfavorable outcomes in COVID-19 patients. High viral loads were associated with unfavorable outcomes but were not independently predictive. Five other predictors were independently associated with increased odds of ICU admission and death.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Immunology

Relationship Between Serum Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid and Organ Damage in Coronavirus 2019 Patients: A Cohort Study

Dan Xu, Fuling Zhou, Wenbo Sun, Liangjun Chen, Lan Lan, Huan Li, Feng Xiao, Ying Li, Vijaya B. Kolachalama, Yirong Li, Xinghuan Wang, Haibo Xu

Summary: The study revealed that serum SARS-CoV-2 RNA was frequently detected in COVID-19 patients between 11 and 15 days after symptom onset. Patients with RNAemia often exhibited organ damage, abnormal laboratory biomarkers, and higher mortality rates.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Single Dose of an mRNA Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) Vaccine Is Associated With Lower Nasopharyngeal Viral Load Among Nursing Home Residents With Asymptomatic Coronavirus Disease 2019 (COVID-19)

M. Catherine McEllistrem, Cornelius J. Clancy, Deanna J. Buehrle, Aaron Lucas, Brooke K. Decker

Summary: A single dose of mRNA SARS-CoV-2 vaccine has been shown to lower the viral load in asymptomatic COVID-19 patients, potentially aiding in controlling outbreaks as viral load is linked to transmission.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Contribution of High Viral Loads, Detection of Viral Antigen and Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity

Felix Buder, Markus Bauswein, Clara L. Magnus, Franz Audebert, Henriette Lang, Christof Kundel, Karin Distler, Edith Reuschel, Matthias Lubnow, Thomas Mueller, Dirk Lunz, Bernhard Graf, Stephan Schmid, Martina Mueller, Hendrik Poeck, Frank Hanses, Bernd Salzberger, David Peterhoff, Jurgen J. Wenzel, Barbara Schmidt, Benedikt M. J. Lampl

Summary: Effective containment strategies for SARS-CoV-2 should balance public health concerns with individual liberties. A study on respiratory samples from patients indicated that high viral load and viral antigen detection increased the likelihood of virus isolation, while symptom onset beyond 10 days and presence of antibodies decreased infectivity. These findings suggest quarantining patients with high viral load and viral antigen detection, and gradually lifting restrictions as time since symptom onset increases and antibodies appear. Delayed antibody formation may lead to prolonged infectivity.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

News Item Multidisciplinary Sciences

COVID VACCINES SLASH VIRAL SPREAD - BUT DELTA IS AN UNKNOWN

Smriti Mallapaty

Summary: Although studies show vaccines reduce the spread of SARS-CoV-2 by more than 80%, the Delta variant is introducing fresh uncertainties.

NATURE (2021)

Add to Collection

Article Immunology

Higher Viral Load Drives Infrequent Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Between Asymptomatic Residence Hall Roommates

Kristen K. Bjorkman, Tassa K. Saldi, Erika Lasda, Leisha Conners Bauer, Jennifer Kovarik, Patrick K. Gonzales, Morgan R. Fink, Kimngan L. Tat, Cole R. Hager, Jack C. Davis, Christopher D. Ozeroff, Gloria R. Brisson, Daniel B. Larremore, Leslie A. Leinwand, Matthew B. McQueen, Roy Parker

Summary: This study analyzed data from 6408 students and identified 116 likely transmission events in residence halls. It found that interroommate transmission occurred infrequently, with only about 20% of cases leading to transmission. Individuals who likely transmitted had higher viral loads compared to those who did not, indicating a correlation between viral load and transmission probability.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 RNAemia and Clinical Outcomes in Children With Coronavirus Disease 2019

Cameron Mertz, Rebecca Glowinski, Shira H. Cohen, Sara Mertz, Fang Ye, Mark W. Hall, Mark E. Peeples, Tiffany King, Huanyu Wang, Amy L. Leber, Pablo J. Sanchez, Octavio Ramilo, Asuncion Mejias

Summary: The burden of coronavirus disease 2019 (COVID-19) in children is relatively small globally, but a subset of hospitalized children with diverse clinical manifestations have been found to have SARS-CoV-2 RNAemia, which is associated with higher rates of oxygen administration, admission to the intensive care unit, and longer hospitalization.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Clinical and Ecological Impact of an Educational Program to Optimize Antibiotic Treatments in Nursing Homes (PROA-SENIOR): A Cluster, Randomized, Controlled Trial and Interrupted Time-Series Analysis

German Penalva, Juan Carlos Crespo-Rivas, Ana Belen Guisado-Gil, Angel Rodriguez-Villodres, Maria Eugenia Pachon-Ibanez, Barbara Cachero-Alba, Blas Rivas-Romero, Josefa Gil-Moreno, Maria Isabel Galva-Borras, Mercedes Garcia-Moreno, Maria Dolores Salamanca-Bautista, Manuel Bautista Martinez-Rascon, Maria Rosa Cantudo-Cuenca, Ruth Concepcion Ninahuaman-Poma, Maria de los Angeles Enrique-Miron, Aurora Perez-Barroso, Inmaculada Marin-Ariza, Miguel Gonzalez-Florido, Maria del Rosario Mora-Santiago, Susana Belda-Rustarazo, Jose Antonio Exposito-Tirado, Clara Maria Rosso-Fernandez, Maria Victoria Gil-Navarro, Jose Antonio Lepe-Jimenez, Jose Miguel Cisneros

Summary: Antimicrobial stewardship programs in nursing homes can improve antibiotic prescribing patterns, reduce antimicrobial use, and decrease the prevalence of multidrug-resistant organisms. The study found that educational programs were effective in achieving these outcomes, even during the COVID-19 pandemic.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Infectious Diseases

Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort

Francesc Escrihuela-Vidal, Achim J. Kaasch, Maja Von Cube, Siegbert Rieg, Winfried V. Kern, Harald Seifert, Kyoung-Ho Song, Chun-Hsing Liao, Robert Tilley, Hannah Gott, Matt Scarborough, Claire Gordon, Martin J. Llewelyn, Richard Kuehl, Laura Morata, Alex Soriano, Jonathan Edgeworth, Enrique Ruiz De Gopegui, Emmanuel Nsutebu, Jose Miguel Cisneros, Vance G. Fowler, Guy Thwaites, Joaquin Lopez-Contreras, Gavin Barlow, Hugo Guillermo Ternavasio-De La Vega, Jesus Rodriguez-Bano, Luis Eduardo Lopez-Cortes

Summary: This study analysed the adherence and impact of quality-of-care indicators (QCIs) in the management of Staphylococcus aureus bloodstream infection. The results showed that adherence to QCIs was associated with reduced 90-day mortality.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Add to Collection

Article Immunology

Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

Mario Fernandez-Ruiz, Marta Bodro, Isabel Gutierrez Martin, Regino Rodriguez-Alvarez, Maria Ruiz-Ruigomez, Nuria Sabe, Teresa Lopez-Vinau, Maricela Valerio, Aitziber Illaro, Jesus Fortun, Sonsoles Salto-Alejandre, Elisa Cordero, Maria del Carmen Farinas, Patricia Munoz, Elisa Vidal, Jordi Carratala, Josune Goikoetxea, Antonio Ramos-Martinez, Asuncion Moreno, Jose Maria Aguado

Summary: Retrospective study shows that isavuconazole is a safe and effective treatment option for invasive mold disease in solid organ transplantation recipients. Clinical response was achieved in over 50% of patients by weeks 6 and 12, and adverse events were relatively low.

TRANSPLANTATION (2023)

Add to Collection

Article Immunology

Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study

Alexander Rombauts, Marta Bodro, Victor Daniel Gumucio, Irene Carbonell, Alex Fava, Laura Llado, Jose Gonzalez-Costello, Federico Oppenheimer, Maria Angeles Castel-Lavilla, Oscar Len, Ester Marquez-Algaba, Xavier Nuvials-Casals, Daniel Martinez Gonzalez, Judith Sacanell Lacasa, Jordi Carratala, Nuria Sabe

Summary: COVID-19-associated pulmonary aspergillosis (CAPA) is common in the ICU, but little is known about its occurrence in solid organ transplant recipients (SOTRs) and the efficacy of antifungal prophylaxis. A retrospective study compared SOTRs with and without nebulized amphotericin-B prophylaxis, showing a lower incidence of pulmonary mold infections in the prophylaxis group. Nebulized amphotericin-B was found to be safe and potentially effective in reducing the risk of CAPA in SOTRs with COVID-19. Further randomized clinical trials are needed to confirm these findings.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2023)

Add to Collection

Article Infectious Diseases

Multidrug-resistant Enterobacterales responsible for septicaemia in a neonatal intensive care unit in Morocco

Patricia Perez-Palacios, Delphine Girlich, Nabila Soraa, Asmae Lamrani, Fadl Mrabih Rabo Maoulainine, Fatiha Bennaoui, Hasna Amri, Nadia Slitine Elidrissi, Mohammed Bouskraoui, Aurelien Birer, Agnes B. Jousset, Saoussen Oueslati, Josette Raymond, Thierry Naas

Summary: The molecular mechanisms of multidrug resistance in bacteria responsible for neonatal sepsis were investigated. Whole-genome sequencing and multi-locus sequence typing were used to characterize the resistome and investigate phylogeny. Among the documented bacteraemia cases, 20% were caused by multidrug-resistant Klebsiella pneumoniae and 10% were caused by multidrug-resistant Enterobacter hormaechei.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2023)

Add to Collection

Article Multidisciplinary Sciences

Analysis of bacterial pangenomes reduces CRISPR dark matter and reveals strong association between membranome and CRISPR-Cas systems

Alejandro Rubio, Maximilian Sprang, Andres Garzon, Antonio Moreno-Rodriguez, Maria Eugenia Pachon-Ibanez, Jeronimo Pachon, Miguel A. Andrade-Navarro, Antonio J. Perez-Pulido

Summary: CRISPR-Cas systems are a type of acquired immunity found in 40% of bacterial genomes, which use small DNA fragments called spacers to prevent viral infections. However, the majority of these spacers, known as CRISPR dark matter, have not been associated with specific viruses. Through analyzing spacers from tens of thousands of genomes, researchers have reduced the amount of CRISPR dark matter from 80% to as low as 15% in some bacterial species. Additionally, it has been observed that genomes with CRISPR-Cas systems also have specific sets of membrane proteins, suggesting a connection between bacterial competitiveness and the acquisition of CRISPR-Cas.

SCIENCE ADVANCES (2023)

Add to Collection

Article Microbiology

In Vitro Activity of Cefiderocol Compared to Other Antimicrobials against a Collection of Metallo-Beta-Lactamase-Producing Gram-Negative Bacilli from Southern Spain

M. Delgado-Valverde, I. Portillo-Calderon, E. Recacha, P. Perez-Palacios, A. Pascual

Summary: This study compared the in vitro activity of cefiderocol with other antimicrobials against MBL-GNB isolates from hospitals in Andalusia, Spain. Cefiderocol showed potent activity against all isolates tested, regardless of breakpoint values.

MICROBIOLOGY SPECTRUM (2023)

Add to Collection

Article Infectious Diseases

Changing Trends in the Global Consumption of Treatments Used in Hospitalized Patients for COVID-19: A Time Series Multicentre Study

Judit Aranda, Jose Loureiro-Amigo, Anna Murgadella, Nuria Vazquez, Lucia Feria, Miriam Munoz, Ariadna Padulles, Gabriela Abelenda, Carol Garcia-Vidal, Montse Tuset, Marta Albanell, Lucia Boix-Palop, Nuria Sanmarti-Martinez, Silvia Gomez-Zorrilla, Daniel Echeverria-Esnal, Alicia Rodriguez-Alarcon, Beatriz Borjabad, Ana Coloma, Jordi Carratala, Isabel Oriol

Summary: This study analyzed the prescription trends of COVID-19 treatments for hospitalized patients in Barcelona. The use of lopinavir/ritonavir and hydroxychloroquine declined over time and was replaced by remdesivir. Tocilizumab use showed a varying trend, while dexamethasone use increased. Antibiotic use, particularly azithromycin, decreased after the initial months of the pandemic. The findings highlight the importance of adapting treatment strategies based on evolving scientific evidence.

ANTIBIOTICS-BASEL (2023)

Add to Collection

Article Infectious Diseases

Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients

Javier Martinez-Casanova, Erika Esteve-Pitarch, Helena Colom-Codina, Victor Daniel Gumucio-Sanguino, Sara Cobo-Sacristan, Evelyn Shaw, Kristel Maisterra-Santos, Joan Sabater-Riera, Xose L. Perez-Fernandez, Raul Rigo-Bonnin, Fe Tubau-Quintano, Jordi Carratala, Ariadna Padulles-Zamora

Summary: This study aimed to characterize the pharmacokinetics of piperacillin after continuous infusion administration in critically ill adult patients and determine the optimal dosing regimen. The population pharmacokinetic approach was used to analyze piperacillin concentrations from 106 patients. Creatinine clearance was found to be the most predictive factor of piperacillin clearance. The model developed can be used for initial dose guidance and therapeutic drug monitoring.

ANTIBIOTICS-BASEL (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Dynamics of Gene Expression Profiling and Identification of High-Risk Patients for Severe COVID-19

Alexander Rombauts, Marta Bodalo Torruella, Gabriela Abelenda-Alonso, Julia Perera-Bel, Anna Ferrer-Salvador, Ariadna Acedo-Terrades, Maria Gabarros-Subira, Isabel Oriol, Carlota Gudiol, Lara Nonell, Jordi Carratala

Summary: The clinical manifestations of SARS-CoV-2 infection vary widely, from asymptomatic infection to severe respiratory complications. The host response to the virus plays a crucial role in determining the outcomes. This study aimed to understand the differences in gene expression and immune response in COVID-19 patients with and without acute respiratory distress syndrome (ARDS). Blood samples were collected from 60 hospitalized patients with confirmed SARS-CoV-2 infection, and significant differences in gene expression were found between the ARDS and non-ARDS groups, including dysregulated inflammatory response and altered immune regulation.

BIOMEDICINES (2023)

Add to Collection

Article Infectious Diseases

Role of bla(TEM) and OmpC in the piperacillin-tazobactam resistance evolution by E. coli in patients with complicated intra-abdominal infection

Lydia Galvez-Benitez, Jose Manuel Ortiz de la Rosa, Angel Rodriguez-Villodres, Carlos S. Casimiro-Soriguer, Irene Molina-Panadero, Rocio Alvarez-Marin, Remy A. Bonnin, Thierry Naas, Jeronimo Pachon, Jose Miguel Cisneros, Jose Antonio Lepe, Younes Smani

Summary: This study aimed to identify the mechanisms underlying Piperacillin-tazobactam resistance (P/T-R) in Escherichia coli. The results showed that P/T-R isolates had a higher copy number of the bla(TEM) gene, generated by three different genetic events. In addition, reduced expression of OmpC was observed in two P/T-R strains. This study provides important insights into the acquisition of P/T-R in E. coli, which is crucial for effective treatment and prevention of resistant microorganisms.

JOURNAL OF INFECTION (2023)

Add to Collection

Article Immunology

Lipid signatures of West Nile virus infection unveil alterations of sphingolipid metabolism providing novel biomarkers

Patricia Mingo-Casas, Javier Sanchez-Cespedes, Ana-Belen Blazquez, Josefina Casas, Maria Balsera-Manzanero, Laura Herrero, Ana Vazquez, Jeronimo Pachon, Manuela Aguilar-Guisado, Jose Miguel Cisneros, Juan-Carlos Saiz, Miguel A. Martin-Acebes

Summary: West Nile virus (WNV) is a neurotropic flavivirus transmitted by mosquitoes and can cause severe diseases. By studying experimentally infected mice and naturally infected patients, dynamic alterations in the lipidome were identified as metabolic fingerprints of different infection stages. The dysregulation of sphingolipid metabolism by WNV may provide new therapeutic opportunities and support the potential of certain lipids as novel peripheral biomarkers of WND progression.

EMERGING MICROBES & INFECTIONS (2023)

Add to Collection

Article Infectious Diseases

Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study

Mar Ronda, Josep Manuel Llop-Talaveron, MariPaz Fuset, Elisabet Leiva, Evelyn Shaw, Victor Daniel Gumucio-Sanguino, Yolanda Diez, Helena Colom, Raul Rigo-Bonnin, Mireia Puig-Asensio, Jordi Carratala, Ariadna Padulles

Summary: This study compared the pharmacokinetics of voriconazole in critically ill patients with and without extracorporeal membrane oxygenation (ECMO) support. The results showed that the ECMO group had lower minimum plasma concentration (C-min) and a higher prevalence of subtherapeutic C-min values. ECMO support and plasma albumin levels were identified as risk factors for low C-min values. Drug optimization is crucial for achieving therapeutic C-min levels in the ECMO group.

ANTIBIOTICS-BASEL (2023)

Add to Collection

Article Dentistry, Oral Surgery & Medicine

Endodontic variables in patients with SARS-CoV-2 infection (COVID-19) in relation to the severity of the disease

Manuel Poyato-Borrego, Maria Leon-Lopez, Jenifer Martin-Gonzalez, Jose M. Cisneros-Herreros, Daniel Cabanillas-Balsera, Juan J. Segura-Egea

Summary: This study analyzed the prevalence of apical periodontitis and the frequency of root canal treatment in patients with SARS-CoV-2 infection, correlating them with the severity of the disease. The results showed that the oral health status of COVID-19 patients correlated with the severity of the SARS-CoV-2 virus infection.

MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL (2023)

Add to Collection

Article Immunology

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

Tomas O. Jensen, Greg A. Grandits, Mamta K. Jain, Thomas A. Murray, Birgit Grund, Kathryn Shaw-Saliba, Michael A. Matthay, Mahsa Abassi, Magdalena Ardelt, Jason V. Baker, Peter Chen, Robin L. Dewar, Anna L. Goodman, Timothy J. Hatlen, Helene C. Highbarger, Mark Holodniy, Perrine Lallemand, Sylvain Laverdure, Bradley G. Leshnower, David Looney, Charalampos D. Moschopoulos, Henry Mugerwa, Daniel D. Murray, Eleftherios Mylonakis, Stephanie Nagy-Agren, M. Tauseef Rehman, Adam Rupert, Randy A. Stevens, Stuart Turville, Amy Weintrob, Katherine Wick, Jens Lundgren, Emily R. Ko

Summary: This study suggests that neutralizing monoclonal antibodies have an antiviral effect among hospitalized patients with COVID-19, without affecting the endogenous anti-nucleocapsid antibody response, systemic inflammation, or clinical status on day 5.

JOURNAL OF INFECTIOUS DISEASES (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.